Iatrogenic oral candidosis.
D000208:Acute Disease; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000906:Antibodies / Q000032:analysis*; D001623:Betamethasone / Q000009:adverse effects*; D002180:Candidiasis, Oral / Q000139:chemically induced* / Q000276:immunology*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007049:Iatrogenic Disease; D007074:Immunoglobulin G / Q000032:analysis*; D007075:Immunoglobulin M / Q000032:analysis*; D013281:Stomatitis, Aphthous / Q000188:drug therapy*; D013752:Tetracycline / Q000009:adverse effects*; D014221:Triamcinolone / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D000906:Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014221:Triamcinolone; D001623:Betamethasone; D013752:Tetracycline; D006854:Hydrocortisone